Show navigation Hide navigation

1. European Society of Cardiology
2. Subspecialty communities
3. European Heart Rhythm Association
4. Research & Publications
5. EHRA Essentials 4 You

 

Industry Essentials

Title	A legacy of differentiated innovation in cardiac ablation
Industry	Medtronic

Title	An innovative cardiac imaging and mapping system based on dielectric sensing; clinical experience and future outlook
Industry	Philips EPD

Title	Cardiac device therapy for heart failure: the future is here
Industry	Medtronic

Title	From His-bundle to leadless pacing: the future is here
Industry	Medtronic

Title	High Density mapping and Local Impedance in an AF procedure
Industry	Boston Scientific

Title	LOCALIZE Trial: The power of Local Impedance
Industry	Boston Scientific

Title	Recent developments in risk stratification and early AF detection for the improved prevention of stroke and systemic embolic events
Industry	Daiichi Sankyo Europe

Title	Remote monitoring of cardiac device patients in the COVID-19 era
Industry	Medtronic

Title	SCD Prevention in 2020 - Minimum Risk for Maximum Benefit
Industry	Boston Scientific

Title	The next level of ultra-HD mapping and ablation: The power of Local Impedance
Industry	Boston Scientific

Title	The state-of-the-art lead extraction program
Industry	Philips

Title	Industry
A legacy of differentiated innovation in cardiac ablation	Medtronic
An innovative cardiac imaging and mapping system based on dielectric sensing; clinical experience and future outlook	Philips EPD
Cardiac device therapy for heart failure: the future is here	Medtronic
From His-bundle to leadless pacing: the future is here	Medtronic
High Density mapping and Local Impedance in an AF procedure	Boston Scientific
LOCALIZE Trial: The power of Local Impedance	Boston Scientific
Recent developments in risk stratification and early AF detection for the improved prevention of stroke and systemic embolic events	Daiichi Sankyo Europe
Remote monitoring of cardiac device patients in the COVID-19 era	Medtronic
SCD Prevention in 2020 - Minimum Risk for Maximum Benefit	Boston Scientific
The next level of ultra-HD mapping and ablation: The power of Local Impedance	Boston Scientific
The state-of-the-art lead extraction program	Philips

×

Sign in to view the resources

 

 

Sign in to view the resources

×

Ask a question

 

 

Sign in to send a question

Live in the box

Case demonstrations of cardiac interventions

Title

Presenter

Abstract

Slides

Voiceover presentation

Ask a question

• Title: Epicardial ablation of a Brugada patient.
  Presenter: C Pappone (San Donato Milanese,IT)
  
  Slides:
  
  Voiceover presentation:
  
  Ask a question: NA
• Title: Ultra-low temperature Cryoablation for AF.
  Presenter: T De Potter (Aalst,BE)
  
  Slides:
  
  Voiceover presentation:
  
  Ask a question: NA

×

Sign in to view the resources

 

 

Sign in to view the resources

×

Ask a question

 

 

Sign in to send a question

Publications

Interact and exchange with the authors using the feature "Ask a question" which will direct your question automatically to the author. Please note the most recent presentations are displayed at the top of the list.

Keywords:

Title

Presenter

Abstract

Slides

Voiceover presentation

Ask a question

EHRA Essentials - Abstract supplement

More than 380 abstracts covering a wide range of topics within your specialty gathered in the abstract supplement of EP Europace, Impact Factor 2018 (5.047)

Access the abstract supplement

New EHRA Consensus document

Risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

This expert consensus statement of the European Heart Rhythm Association (EHRA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS) provides physicians with practical proposals that may lead to improvement of patient care.

  Read the article

This Content Component encountered an error

Scientific News

Date

Title

• Date: 27/04/2020
  Title: Redefining response to CRT: Insights from the REVERSE trial